Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2026-01-20 @ 8:14 PM
Study NCT ID:
NCT05782361
Status:
RECRUITING
Last Update Posted:
2025-08-20
First Post:
2023-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
Sponsor:
Organization: